Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MANÜ Telehealth vs YOURx Health

MANÜ Telehealth
Graded #83

Higher grade

vs+2.200000000000003
YOURx Health
Graded #109

Lower grade

The verdict

MANÜ Telehealth takes it — 72.2/100 to 70/100.

MANÜ Telehealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MANÜ Telehealth is a US online platform offering compounded GLP-1 weight loss medication including injectable tirzepatide and semaglutide, with add-ons like MIC Ultraburn and NAD+ injections.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMANÜ Telehealth +18
85
67
Dose & formulationYOURx Health +11
64
75
Clinical oversightYOURx Health +1
79
80
Labs & monitoringYOURx Health +12
63
75
FulfillmentMANÜ Telehealth +16
71
55
Contract termsEven
55
55
MANÜ Telehealth · left barYOURx Health · right bar

The numbers

MetricMANÜ TelehealthYOURx Health
WeighScore72.2/10070/100
GradeCC
Scorecard rank#83#109
Semaglutide$120/mo (compounded)$179/mo (compounded)
Tirzepatide$150/mo (compounded)$199/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
MANÜ Telehealth

Graded #83 · C

Strengths

  • Compounded GLP-1s advertised from about $4-$5/day
  • 100% online with free discreet shipping and no insurance needed
  • Compounds exclusively from US 503A pharmacies
  • Add-on options like MIC Ultraburn and NAD+

Where it loses points

  • Per-dose pricing is gated behind login/signup, not public
  • State availability changes and is only confirmed at signup
  • Compounded medications are not FDA-evaluated
YOURx Health

Graded #109 · C

Strengths

  • Lab monitoring included (per the home page) — most peer platforms gate labs as add-ons or skip them entirely
  • Physician video consultation with 'board-certified provider' disclosed
  • MD Integrations network is a recognized white-label clinical platform
  • Transparent published pricing: semaglutide injection $179/mo, tirzepatide injection $199/mo, oral RDT tablets $159-$179/mo

Where it loses points

  • Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
  • NO LegitScript / NABP / PCAB / BBB seal displayed — material trust-signal gap vs peer platforms
  • Per-state availability shown as 'Coverage 0 States' (placeholder metric) — appears the home page is incomplete or the platform is pre-launch
  • Pharmacy partners NOT publicly named
  • Confidence LOW until the platform exposes more public information

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard